You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

CLINICAL TRIALS PROFILE FOR EQUETRO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for EQUETRO

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00181870 ↗	Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder	Completed	Shire	Phase 4	2005-07-01	This is an open-label pilot study of up to 1200 mg/day of carbamazepine ER (Equetro) in the treatment of children who meet DSM-IV criteria for Bipolar I, Bipolar II, or Bipolar Spectrum Disorder. The main goal of this study is to begin to address the void of information on safety, tolerability and effectiveness of Equetro in the treatment of Pediatric Bipolar Disorder.
NCT00181870 ↗	Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder	Completed	Massachusetts General Hospital	Phase 4	2005-07-01	This is an open-label pilot study of up to 1200 mg/day of carbamazepine ER (Equetro) in the treatment of children who meet DSM-IV criteria for Bipolar I, Bipolar II, or Bipolar Spectrum Disorder. The main goal of this study is to begin to address the void of information on safety, tolerability and effectiveness of Equetro in the treatment of Pediatric Bipolar Disorder.
NCT00203567 ↗	Carbamazepine Extended-Release for the Treatment of Bipolar Depression	Completed	Shire	Phase 4	2005-08-01	To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for EQUETRO

Condition Name

Chart
Table

Condition Name for EQUETRO
Intervention	Trials
Bipolar Disorder	3
Bipolar Depression	1
Mania	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for EQUETRO
Intervention	Trials
Bipolar Disorder	4
Disease	3
Mania	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for EQUETRO

Trials by Country

Map
Table

Trials by Country for EQUETRO
Location	Trials
United States	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for EQUETRO
Location	Trials
Texas	1
Missouri	1
Maryland	1
Florida	1
Nebraska	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for EQUETRO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for EQUETRO
Clinical Trial Phase	Trials
Phase 4	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for EQUETRO
Clinical Trial Phase	Trials
Completed	2
Unknown status	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EQUETRO

Sponsor Name

Chart
Table

Sponsor Name for EQUETRO
Sponsor	Trials
Shire	3
Massachusetts General Hospital	1
Tuscaloosa Research & Education Advancement Corporation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for EQUETRO
Sponsor	Trials
Industry	4
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.